Pharmaceuticals, Biotechnology and Life Sciences
– Randomized, 12-Month, Pivotal Trial Evaluating the Safety and Efficacy of Patidegib Topical Gel to Reduce the Disease Burden of…
–Oral presentation highlights encouraging outcomes in patients with advanced renal cell carcinoma -Data supports continued clinical development with planned PT2977…
LOS ANGELES & CASTRES, France–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI) and Pierre Fabre have entered into an exclusive license agreement…
RC-01 represents a new class of antibiotics in development for the treatment of serious antibiotic-resistant infections MENLO PARK, Calif.–(BUSINESS WIRE)–Recida…
Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility…
$12 million in extension funding announced Karuna awarded U.S. Patent covering lead product candidate, KarXT BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (“Karuna”)…
SKOKIE, Ill.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs,…
KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a…
Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas Selumetinib Is a MEK 1/2 Inhibitor…